Skip to main content

Zerhouni's Departure from NIH Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 26.
 
1. NIH Director Elias Zerhouni to Step Down; Kington Likely to Serve as Acting Director (from Sept. 24)
 
2. Sequenom Shares Soar on Down Syndrome Test Results (from Sept. 24)
 
3. NIH Awards $138M for 'Deep Innovation,' Including Genomics, Proteomics Research (from Sept. 22)
 
4. PacBio Eyes Clinical Diagnostic Market for Third-Gen Sequencing Platform (from Sept. 24)
 
5. Sequenom Buys Michigan CLIA Lab for $4M (from Sept. 23)
The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.